DRKS00017409尚未招募不适用
og-term follow-up of patients with cerebral AVM-hemorrhage, with particular attention to functional quality of life and socioeconomic status.
Goethe Universitätsklinik FrankfurtNeurochirurgie0 个研究点目标入组 60 人开始时间: 2019年7月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •Arteriovenous Malformation
排除标准
- •No Arteriovenous malformation
- •lost to follow-up
研究者
相似试验
已完成
不适用
Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic AgentCerebral Arteriovenous MalformationsNCT02602990Emboflu50
招募中
不适用
ongterm follow-up of patients treated with Lenti-D for an inherited brain disorderRBR-72wbbgBlanchard y Asociados
招募中
3 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductCALDcerebral adrenoleukodystrophy10029299NL-OMON54368bluebird bio, Inc.3
进行中（未招募）
1 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductEUCTR2015-002805-13-DEbluebird bio, Inc67
进行中（未招募）
1 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductEUCTR2015-002805-13-NLbluebird bio, Inc60